Skip to content

Evaluation of the clinical effect of azathioprine lozenge in oral lichen planus

Evaluation of the effect of azathioprine lozenge to improve symptoms of patient with oral lichen planus: An experimental study and a double-blinded randomized clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191106045356N10
Enrollment
50
Registered
2021-12-21
Start date
2022-01-21
Completion date
Unknown
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oral lichen planus. Lichen planus

Interventions

Intervention 1: Intervention group: Includes 25 patients who are diagnosed with oral lichen planus based on the patient's examination by a dentist or biopsy of the tissue of one or more ulcers in the

Sponsors

Yazd University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Women should not be pregnant or breastfeeding Do not use allopurinol Do not use viral vaccines during treatment Patients do not have a confirmed history of allergic reactions following oral administration of azathioprine The patient does not have a low level of consciousness The patient should not be treated with warfarin The patient does not have an active viral disease

Exclusion criteria

Exclusion criteria: Do not use the drug for two consecutive days Exacerbation of oral lichen planus lesions Allergic reaction to azathioprine

Design outcomes

Primary

MeasureTime frame
Redness and inflammation. Timepoint: At the beginning of treatment and after every 2 to 10 days, the status of oral lichen planus lesions is evaluated for the severity of redness and inflammation (score 0 to 4). Method of measurement: Scoring severe redness and inflammation using a Reeda questionnaire.;Severe pain and burning. Timepoint: At the beginning of treatment and after every 2 to 10 days, the condition of oral lichen planus lesions is evaluated for the severity of pain and burning (score 0 to 4). Method of measurement: Severe pain and burning using VAS questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mohsen Zabihi

Yazd University of Medical Sciences

mzabihi100@gmail.com+98 35 3820 3865

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026